Skip to search formSkip to main contentSkip to account menu

belimumab

Known as: Immunoglobulin G1, anti-(Human Cytokine BAFF) (Human Monoclonal LymphoStat-B Heavy Chain), Disulfide with Human Monoclonal LymphoStat-B lambda-chain, Dimer 
A fully human IgG1 monoclonal antibody directed against B-Lymphocyte stimulator protein (BlyS or TNFSF13B) with potential immunomodulating activity… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Review
2013
Review
2013
2013
2013
This Phase 1 study evaluated the absolute bioavailability, pharmacokinetics (PK), tolerability, and safety of belimumab 200 mg/mL… 
Review
2008
Review
2008
Background: B lymphocyte stimulator (BLyS) is a factor determining the survival of B cells, and elevated levels in serum or… 
Review
2008